Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7915447

NC(=O)C1CCN(CCNc2ccnc(N)c2Cl)C1=O.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F

nearest known ligand 0.34

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 7/20 0.33
HRH3 Q9Y5N1 7/20 0.33
MET P08581 1/20 0.32
APAF1 O14727 1/20 0.31
MITF O75030 1/20 0.31
CASP7 P55210 1/20 0.31
CASP9 P55211 1/20 0.31
CASP6 P55212 1/20 0.31
CASP8 Q14790 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
F2 P00734 1/20 0.31
F10 P00742 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7915271 1.00 HRH4 (0.33) HRH4HRH3METAPAF1MITF
Trifluoroacetic Acid SCHEMBL7915274 0.89 HRH4 (0.36) HRH4HRH3METAPAF1MITF
Trifluoroacetic Acid SCHEMBL7376993 0.80 GPR6 (0.36) HRH4HRH3APAF1MITFCASP7
Trifluoroacetic Acid SCHEMBL7370016 0.80 GPR6 (0.36) HRH4HRH3APAF1MITFCASP7
Trifluoroacetic Acid SCHEMBL7921642 0.80 GPR6 (0.36) HRH4HRH3APAF1MITFCASP7
Trifluoroacetic Acid SCHEMBL7377206 0.76 F10 (0.49) F2F10
Trifluoroacetic Acid SCHEMBL7375929 0.75 F10 (0.56) F2F10
Trifluoroacetic Acid SCHEMBL7378459 0.75 F10 (0.51) F2F10
SCHEMBL7378733 0.73 CYP2D6 (0.35) L3MBTL1F2F10
SCHEMBL7540081 0.73 CYP2D6 (0.35) L3MBTL1F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6281227-B1 INHIBITORS OF THE ACTIVITY OF FACTOR XA. AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-28 US claimed
US-6281227-B1 INHIBITORS OF THE ACTIVITY OF FACTOR XA. AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-28 US disclosed